Panzyga is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Panzyga is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand namePanzyga
Authorized genericimmune globulin intravenous (human)
Regular genericimmune globulin intravenous (human)
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Panzyga?
The original
–
–

Brand nameThe maker’s card

PANZYGA Co-Pay Program (Pfizer IGuide)

Savings card from Pfizer

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a treatment

The card takes up to $12,500 a year off your co-pay.

Sign up on pfizeriguide.com 

In the maker’s words

“Eligible enrolled patients may pay as little as $0 per treatment.”

From the maker’s offer on pfizeriguide.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Panzyga itself, from the same company, sold without the brand name, and usually for less. For now Panzyga is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Panzyga is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

PANZYGA is an immune globulin intravenous (human) - ifas 10% liquid preparation indicated for the treatment of:

Primary humoral immunodeficiency (PI) in patients 2 years of age and older.

Chronic immune thrombocytopenia (ITP) in adults.

Chronic inflammatory demyelinating polyneuropathy (CIDP) in adults

Source: the FDA label for Panzyga (Pfizer Laboratories Div Pfizer Inc), May 8, 2025. Full label on DailyMed 

Good to know